Non-Inferiority Trials
Author:
- Rick ChappellRCRick Chappell
- 12 April 2012
- book chapter
- Published by Cambridge University Press (CUP)
- p. 135-146
Abstract
This chapter focuses on the challenges presented by therapeutic targets in the central nervous system (CNS), the manner in which animal models have and can be used to support the translation of therapeutic biologies to the human CNS, the blood brain barrier (BBB), and the uncertainties of CNS drug exposures. It also addresses how these challenges can be met and the associated risks of CNS therapeutic development mitigated. Animal CNS disease models are unique tools that have led to a significant increase in the number of potential new therapeutic targets and an improved understanding of the biologies underlying disease processes. Development of pharmacodynamic (Pd) biomarkers for CNS drug development should be a high priority. Pd biomarkers are used in Phase 1, 2, and 3 studies, although most commonly in Phase 1 and 2 studies.Keywords
This publication has 26 references indexed in Scilit:
- Randomized Clinical Trial Design for Assessing Noninferiority When Superiority Is ExpectedJournal of Clinical Oncology, 2007
- The role of intention to treat in analysis of noninferiority studiesClinical Trials, 2007
- Current issues in non‐inferiority trialsStatistics in Medicine, 2007
- Trials and Tribulations of Non-InferiorityJACC, 2005
- Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?Stroke, 2004
- Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V)American Heart Journal, 2003
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001
- Acute strokeWestern Journal of Medicine, 2000
- The role of randomization in clinical trialsStatistics in Medicine, 1982
- The Design and Analysis of ExperimentsSoil Science, 1952